Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A2LP
|
|||
| Former ID |
DNC013395
|
|||
| Drug Name |
2-methyl-7-m-tolyl-1,8-naphthyridine
|
|||
| Synonyms |
CHEMBL235629; 2-methyl-7-m-tolyl-1,8-naphthyridine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H14N2
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)C2=NC3=C(C=CC(=N3)C)C=C2
|
|||
| InChI |
1S/C16H14N2/c1-11-4-3-5-14(10-11)15-9-8-13-7-6-12(2)17-16(13)18-15/h3-10H,1-2H3
|
|||
| InChIKey |
RJHUNTTZZMJQOV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.